Related Experiment Video
Updated: Jul 10, 2025
09:13
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.4K
Antiplasmodial peptaibols act through membrane directed mechanisms
Jennifer E Collins1, Jin Woo Lee2, Frances Rocamora3
1Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32826, USA.
Cell Chemical Biology
|November 23, 2023
Summary
This study reveals that peptaibols, derived from fungi, target the digestive vacuole in Plasmodium falciparum, offering a novel mechanism against malaria. Resistance arises from mutations in the pfmdr1 gene, suggesting distinct therapeutic pathways.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Molecular Biology
Background:
- Fungal-derived peptaibols show antiplasmodial activity.
- Understanding the mechanism of action is crucial for drug development.
Purpose of the Study:
- To elucidate the antiplasmodial mechanism of action of fungal peptaibols.
- To investigate resistance mechanisms and stage dependency of potent peptaibols.
Main Methods:
- Phenotypic assays
- In vitro resistance evolution studies
- Transcriptome analysis
- Ultrastructural analysis
- Planar membrane reconstitution assays
Main Results:
- The potent peptaibol HZ NPDG-I disrupts the digestive vacuole (DV) by increasing pH and impairing membrane permeability.
- HZ NPDG-I forms ion channels and exhibits no cross-resistance with current antimalarial drugs.
- Resistance to HZ NPDG-I is mediated by mutations in the Plasmodium falciparum multidrug resistance transporter gene (pfmdr1).
Conclusions:
- Fungal peptaibols represent a promising class of antimalarials with a novel mechanism targeting the parasite's digestive vacuole.
- PfMDR1 is implicated in resistance to certain peptaibols, indicating potential for drug combination therapies or tailored drug selection.
Keywords:
AMPsAlamethicinMDR1Plasmodiumantiplasmodialdigestive vacuoleion channelmalariapeptaibolpeptidesMore Related Videos
Related Concept Videos
01:42Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
534
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
534
01:11IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
01:19Membrane Asymmetry Regulating Transporters
4.5K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
4.5K